<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2328-9503</journal-id>
<journal-id journal-id-type="publisher-id">ACN3</journal-id>
<journal-title-group>
<journal-title>Annals of Clinical and Translational Neurology</journal-title>
</journal-title-group>
<issn pub-type="epub">2328-9503</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30349862</article-id>
<article-id pub-id-type="pmc">6186933</article-id>
<article-id pub-id-type="doi">10.1002/acn3.622</article-id>
<article-id pub-id-type="publisher-id">ACN3622</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Brief Communication</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Brief Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenotypic expansion in <italic><styled-content style="fixed-case">DDX</styled-content>3X</italic> – a common cause of intellectual disability in females</article-title>
<alt-title alt-title-type="left-running-head">X. Wang <italic>et al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="acn3622-cr-0001">
<name>
<surname>Wang</surname>
<given-names>Xia</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7750-1167</contrib-id>
<address>
<email>xiaw@bcm.edu</email>
</address>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0002">
<name>
<surname>Posey</surname>
<given-names>Jennifer E.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0003">
<name>
<surname>Rosenfeld</surname>
<given-names>Jill A.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5664-7987</contrib-id>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0004">
<name>
<surname>Bacino</surname>
<given-names>Carlos A.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0005">
<name>
<surname>Scaglia</surname>
<given-names>Fernando</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0006">
<name>
<surname>Immken</surname>
<given-names>LaDonna</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0007">
<name>
<surname>Harris</surname>
<given-names>Jill M.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0008">
<name>
<surname>Hickey</surname>
<given-names>Scott E.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0006">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0009">
<name>
<surname>Mosher</surname>
<given-names>Theresa M.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0010">
<name>
<surname>Slavotinek</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0011">
<name>
<surname>Zhang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0012">
<name>
<surname>Beuten</surname>
<given-names>Joke</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0013">
<name>
<surname>Leduc</surname>
<given-names>Magalie S.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0014">
<name>
<surname>He</surname>
<given-names>Weimin</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0015">
<name>
<surname>Vetrini</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0016">
<name>
<surname>Walkiewicz</surname>
<given-names>Magdalena A.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0017">
<name>
<surname>Bi</surname>
<given-names>Weimin</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0018">
<name>
<surname>Xiao</surname>
<given-names>Rui</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0019">
<name>
<surname>Liu</surname>
<given-names>Pengfei</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0020">
<name>
<surname>Shao</surname>
<given-names>Yunru</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0021">
<name>
<surname>Gezdirici</surname>
<given-names>Alper</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0022">
<name>
<surname>Gulec</surname>
<given-names>Elif Y.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0023">
<name>
<surname>Jiang</surname>
<given-names>Yunyun</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0024">
<name>
<surname>Darilek</surname>
<given-names>Sandra A.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0025">
<name>
<surname>Hansen</surname>
<given-names>Adam W.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0026">
<name>
<surname>Khayat</surname>
<given-names>Michael M.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0027">
<name>
<surname>Pehlivan</surname>
<given-names>Davut</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0028">
<name>
<surname>Piard</surname>
<given-names>Juliette</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0012">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0029">
<name>
<surname>Muzny</surname>
<given-names>Donna M.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0030">
<name>
<surname>Hanchard</surname>
<given-names>Neil</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0031">
<name>
<surname>Belmont</surname>
<given-names>John W.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0032">
<name>
<surname>Van Maldergem</surname>
<given-names>Lionel</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0012">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0033">
<name>
<surname>Gibbs</surname>
<given-names>Richard A.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0034">
<name>
<surname>Eldomery</surname>
<given-names>Mohammad K.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0035">
<name>
<surname>Akdemir</surname>
<given-names>Zeynep C.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0036">
<name>
<surname>Adesina</surname>
<given-names>Adekunle M.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0013">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0037">
<name>
<surname>Chen</surname>
<given-names>Shan</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0038">
<name>
<surname>Lee</surname>
<given-names>Yi‐Chien</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0039">
<collab collab-type="authors">Undiagnosed Diseases Network</collab>
<xref ref-type="author-notes" rid="acn3622-note-1002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0040">
<name>
<surname>Lee</surname>
<given-names>Brendan</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0041">
<name>
<surname>Lupski</surname>
<given-names>James R.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0042">
<name>
<surname>Eng</surname>
<given-names>Christine M.</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0043">
<name>
<surname>Xia</surname>
<given-names>Fan</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0044">
<name>
<surname>Yang</surname>
<given-names>Yaping</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="acn3622-cr-0045">
<name>
<surname>Graham</surname>
<given-names>Brett H.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8451-8154</contrib-id>
<address>
<email>bregraha@iu.edu</email>
</address>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0014">
<sup>14</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3622-cr-0046">
<name>
<surname>Moretti</surname>
<given-names>Paolo</given-names>
</name>
<xref ref-type="aff" rid="acn3622-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="acn3622-aff-0015">
<sup>15</sup>
</xref>
</contrib>
</contrib-group>
<aff id="acn3622-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Molecular and Human Genetics</named-content>
<institution>Baylor College of Medicine</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0002">
<label><sup>2</sup></label>
<institution>Baylor Genetics</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0003">
<label><sup>3</sup></label>
<institution>Texas Children's Hospital</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Neurology</named-content>
<institution>Baylor College of Medicine and Michael E. DeBakey VA Medical Center</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0005">
<label><sup>5</sup></label>
<institution>Specially for Children</institution>
<named-content content-type="city">Austin</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Clinical Pediatrics</named-content>
<institution>The Ohio State University</institution>
<named-content content-type="city">Columbus</named-content>
<named-content content-type="country-part">Ohio</named-content>
</aff>
<aff id="acn3622-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Division of Molecular &amp; Human Genetics</named-content>
<institution>Nationwide Children's Hospital</institution>
<named-content content-type="city">Columbus</named-content>
<named-content content-type="country-part">Ohio</named-content>
</aff>
<aff id="acn3622-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<named-content content-type="organisation-division">Division of Genetics</named-content>
<institution>University of California</institution>
<named-content content-type="city">San Francisco</named-content>
<named-content content-type="country-part">California</named-content>
</aff>
<aff id="acn3622-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Department of Genetics</named-content>
<institution>Kanuni Sultan Suleyman Training and Research Hospital</institution>
<named-content content-type="city">Instanbul</named-content>
<country country="TR">Turkey</country>
</aff>
<aff id="acn3622-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Section of Neurology</named-content>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>Baylor College of Medicine</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0011">
<label><sup>11</sup></label>
<named-content content-type="organisation-division">Human Genome Sequencing Center</named-content>
<institution>Baylor College of Medicine</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0012">
<label><sup>12</sup></label>
<named-content content-type="organisation-division">Centre de Génétique Humaine</named-content>
<institution>Université de Franche‐Comté</institution>
<named-content content-type="city">Besançon</named-content>
<country country="FR">France</country>
</aff>
<aff id="acn3622-aff-0013">
<label><sup>13</sup></label>
<named-content content-type="organisation-division">Pathology</named-content>
<institution>Baylor College of Medicine</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">Texas</named-content>
</aff>
<aff id="acn3622-aff-0014">
<label><sup>14</sup></label>
<named-content content-type="organisation-division">Medical and Molecular Genetics</named-content>
<institution>Indiana University School of Medicine</institution>
<named-content content-type="city">Indianapolis</named-content>
<country>Indiana</country>
</aff>
<aff id="acn3622-aff-0015">
<label><sup>15</sup></label>
<named-content content-type="organisation-division">Neurology</named-content>
<institution>University of Utah and George E. Wahlen VA Medical Center</institution>
<named-content content-type="city">Salt Lake City</named-content>
<named-content content-type="country-part">Utah</named-content>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Xia Wang, Department of Molecular and Human Genetics, Baylor College of Medicine, 2450 Holcombe Blvd, Houston, TX 77021. Tel: +1 713 798 1221; E‐mail: <email>xiaw@bcm.edu</email><break></break>
Paolo Moretti, Department of Neurology, University of Utah, 729 Arapeen Drive, Salt Lake City, UT 84108. Tel: +1 801 585 7808; Fax: +1 801 587 8381; E‐mail: <email>paolo.moretti@hsc.utah.edu</email><break></break>
Brett H. Graham, Department of Medical and Molecular Genetics, Indiana University, IUPUI ‐ Van Nuys Medical Science Building, 635 Barnhill Drive, MS 1015, Indianapolis, IN 46202. Tel: +1 317 274 5607; Fax: +1 317 278 0936; E‐mail: <email>bregraha@iu.edu</email><break></break></corresp>
<fn id="acn3622-note-1002">
<label>†</label>
<p>Members are listed in Table <xref ref-type="supplementary-material" rid="acn3622-sup-0004">S3</xref>.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2018</year>
</pub-date>
<volume>5</volume>
<issue>10</issue>
<issue-id pub-id-type="doi">10.1002/acn3.2018.5.issue-10</issue-id>
<fpage>1277</fpage>
<lpage>1285</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 American Neurological Association <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Annals of Clinical and Translational Neurology</italic> published by Wiley Periodicals, Inc on behalf of American Neurological Association.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:ACN3-5-1277.pdf" xlink:type="simple"></self-uri>
<abstract id="acn3622-abs-0001">
<title>Abstract</title>
<p>De <italic>novo</italic> variants in <italic><styled-content style="fixed-case">DDX</styled-content>3X</italic> account for 1–3% of unexplained intellectual disability (<styled-content style="fixed-case">ID</styled-content>) cases and are amongst the most common causes of <styled-content style="fixed-case">ID</styled-content> especially in females. Forty‐seven patients (44 females, 3 males) have been described. We identified 31 additional individuals carrying 29 unique <italic><styled-content style="fixed-case">DDX</styled-content>3X</italic> variants, including 30 postnatal individuals with complex clinical presentations of developmental delay or <styled-content style="fixed-case">ID</styled-content>, and one fetus with abnormal ultrasound findings. Rare or novel phenotypes observed include respiratory problems, congenital heart disease, skeletal muscle mitochondrial <styled-content style="fixed-case">DNA</styled-content> depletion, and late‐onset neurologic decline. Our findings expand the spectrum of <styled-content style="fixed-case">DNA</styled-content> variants and phenotypes associated with <italic><styled-content style="fixed-case">DDX</styled-content>3X</italic> disorders.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>National Human Genome Research Institute/National Heart Lung and Blood Institute</funding-source>
<award-id>UM1 HG006542</award-id>
</award-group>
<award-group>
<funding-source>NIH Common Fund</funding-source>
<award-id>U01HG007709</award-id>
</award-group>
<funding-statement>This work was funded by <funding-source>National Human Genome Research Institute/National Heart Lung and Blood Institute</funding-source> grant <award-id>UM1 HG006542</award-id>; <funding-source>NIH Common Fund</funding-source> grant <award-id>U01HG007709</award-id>. </funding-statement>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<page-count count="9"></page-count>
<word-count count="5120"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>acn3622</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>October 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.0.1 mode:remove_FC converted:15.10.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group id="acn3622-ntgp-0001">
<fn fn-type="funding" id="acn3622-note-1001">
<p>
<bold>Funding Information</bold> Research reported in this manuscript was supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under Award Number U01HG007709, and the National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) UM1 HG006542 to the Baylor Hopkins Center for Mendelian Genomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J. E. P. was supported by K08 HG008986 through the National Human Genome Research Institute.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="acn3622-sec-0001">
<title>Introduction</title>
<p>Intellectual disability (ID) affects 1–3% of the population and is more prevalent in males versus females.<xref ref-type="ref" rid="acn3622-bib-0001">1</xref> Although over 100 genes on the X chromosome were found to be associated with ID in males,<xref ref-type="ref" rid="acn3622-bib-0002">2</xref>, <xref ref-type="ref" rid="acn3622-bib-0003">3</xref> relatively less is known about X‐linked ID genes in females.<xref ref-type="ref" rid="acn3622-bib-0004">4</xref> Whole‐exome sequencing (WES) is finding <italic>de novo</italic> variants in X‐linked ID genes in females of all ages.<xref ref-type="ref" rid="acn3622-bib-0005">5</xref>, <xref ref-type="ref" rid="acn3622-bib-0006">6</xref>, <xref ref-type="ref" rid="acn3622-bib-0007">7</xref>, <xref ref-type="ref" rid="acn3622-bib-0008">8</xref> However, limited information is available regarding such cases. Some of the genes causing ID in females are known to cause disease in males, including <italic>PHF6,</italic>
<xref ref-type="ref" rid="acn3622-bib-0009">9</xref>
<italic>NEXMIF,</italic>
<xref ref-type="ref" rid="acn3622-bib-0008">8</xref> and <italic>USP9X</italic>, with the latter causing congenital malformations not observed in affected males.<xref ref-type="ref" rid="acn3622-bib-0010">10</xref> Further evidence for gender‐specific variant pathogenicity comes from <italic>DDX3X</italic> located on Xp11.4, with pathogenic <italic>de novo</italic> variants causing syndromic ID in 39 females; in the same study, three males inherited <italic>DDX3X</italic> variants from apparently unaffected mothers.<xref ref-type="ref" rid="acn3622-bib-0011">11</xref> Differences in predicted variant severity or X‐chromosome inactivation studies from blood DNA did not explain the gender‐specific disease expression. Five additional females with <italic>DDX3X</italic> variants have been described in the literature.<xref ref-type="ref" rid="acn3622-bib-0012">12</xref>, <xref ref-type="ref" rid="acn3622-bib-0013">13</xref>, <xref ref-type="ref" rid="acn3622-bib-0014">14</xref> These reports led us to hypothesize that females with <italic>de novo</italic> variation in <italic>DDX3X</italic> may show additional clinical phenotypes. We report 31 individuals with <italic>DDX3X</italic>‐related disorders, and provide comprehensive clinical presentations for 13, including expanding the age range of molecular diagnosis with the oldest reported individual and a fetus. These data expand the number of <italic>DDX3X</italic> pathogenic variants and their associated phenotypic spectrum.</p>
</sec>
<sec id="acn3622-sec-0002">
<title>Methods</title>
<p>Variants in <italic>DDX3X</italic> were identified by WES, performed according to previously described methods,<xref ref-type="ref" rid="acn3622-bib-0005">5</xref>, <xref ref-type="ref" rid="acn3622-bib-0006">6</xref>, <xref ref-type="ref" rid="acn3622-bib-0013">13</xref> either on a clinical basis at Baylor Genetics (Females 1–24, Males 1–2, Fetus 1) or on a research basis by the Baylor Hopkins Center for Mendelian Genomics (BHCMG, Females 25–27) or through the Centre de Génétique Humaine, Université de Franche‐Comté (Female 28). Deidentified reporting of aggregated demographic and molecular data for all clinically referred cases was approved by the Institutional Review Board at Baylor College of Medicine (BCM). Additional, informed consent for publication of clinical details was obtained for a subset of clinically referred cases and all research‐based cases according to IRB‐approved protocols: at Baylor College of Medicine (Female 8, 14, 17, 23, 24, 26), through the Undiagnosed Diseases Network (UDN) protocol (Female 13), and through the BHCMG (Females 7, 19, 25, 27); and at Centre de Génétique Humaine, Université de Franche‐Comté (Female 28). Females 7 and 19 were previously reported in a study of research‐based reanalysis of clinical WES data.<xref ref-type="ref" rid="acn3622-bib-0013">13</xref>
<italic>DDX3X</italic> variants were annotated using transcript NM_001193416. Variant pathogenicity was determined based on the ACMG guidelines<xref ref-type="ref" rid="acn3622-bib-0015">15</xref> and the internal guidelines developed at Baylor Genetics (<ext-link ext-link-type="uri" xlink:href="https://www.baylorgenetics.com/variant-classification/">https://www.baylorgenetics.com/variant-classification/</ext-link>). For the interpretation of <italic>de novo</italic> variants, the PS2 evidence is used if rare and/or private variants in the proband were detected in both parents by WES (Trio WES) or Sanger sequencing (proband only WES). Otherwise the PM6 evidence is used. 0.1–1 <italic>μ</italic>g total RNA from patient fibroblast cells was extracted for library preparation with TruSeq Stranded mRNA kit and was sequenced by Illumina NextSeq 550. Genes with expression at the top/bottom 5% were used for pathway enrichment analysis by Ingenuity Pathway Analysis (IPA, QIAGEN Inc., <ext-link ext-link-type="uri" xlink:href="https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis">https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis</ext-link>).</p>
</sec>
<sec id="acn3622-sec-0003">
<title>Results</title>
<p>Among 4839 (2152 females, 2687 males) patients referred to the Baylor Genetics laboratory for clinical WES with developmental delay (DD) and/or ID, 26 postnatal individuals (24 females, 2 males) were found to carry pathogenic or likely pathogenic variants in <italic>DDX3X</italic>, and 1 female fetus was found to carry a <italic>de novo</italic> variant of unknown significance in <italic>DDX3X</italic>. Through collaboration with the BHCMG and Centre de Génétique Humaine, Université de Franche‐Comté, an additional four unrelated female cases (Females 25–28) were identified. The ages at molecular diagnosis of the postnatal individuals ranged from 1 to 47 years (Table <xref ref-type="supplementary-material" rid="acn3622-sup-0002">S1</xref>). Twenty‐nine unique variants were identified (26 novel and 3 reported previously), including 13 missense, 6 frameshift, 3 splice site, 4 nonsense, and 3 in‐frame deletion/duplication changes (Table <xref ref-type="table" rid="acn3622-tbl-0001">1</xref> and Fig. <xref ref-type="fig" rid="acn3622-fig-0001">1</xref>A and B). In 29 individuals with available parents (27 female, 1 male, 1 fetus), the <italic>DDX3X</italic> variants were confirmed as <italic>de novo</italic>, supporting the variant pathogenicity. Two <italic>de novo</italic> variants, c.573_575del (p.I191del) and c.1805G&gt;A (p.R602Q) are mosaic in the proband, with allele fractions of 21% and 14%, respectively (Table <xref ref-type="table" rid="acn3622-tbl-0001">1</xref>). The most frequent clinical presentations in the 28 females include DD and/or ID (28/28), hypotonia (19/28), dysmorphic features (19/28), structural brain abnormalities (18/20 who had brain MRI, Fig. <xref ref-type="supplementary-material" rid="acn3622-sup-0001">S1</xref>), movement disorders (17/28), visual impairments (9/28), and microcephaly (7/28) (Table <xref ref-type="table" rid="acn3622-tbl-0002">2</xref>). The most commonly observed dysmorphic facial features include a high‐arched palate (5/19), thin upper lip (5/19), large ears (5/19), and long/smooth/large philtrum (4/19). Clinical presentations that are not present in published studies include respiratory problems (5/28): obstructive sleep apnea, tachypnea, and chronic respiratory failure, as well as congenital heart disease (5/7 who had echocardiogram): atrial/ventricular septal defect, double orifice mitral valve with small patent ductus arteriosus, mild concentric left ventricular hypertrophy and bicuspid aortic valve. In comparison to published data, autism spectrum disorder and other behavior problems and skin abnormalities are underrepresented in our cohort (Table <xref ref-type="table" rid="acn3622-tbl-0002">2</xref>). For 13 subjects, we obtained additional informed consent and provide detailed clinical descriptions (Table <xref ref-type="supplementary-material" rid="acn3622-sup-0002">S1</xref>), as well as clinical images for two subjects (Fig. <xref ref-type="fig" rid="acn3622-fig-0001">1</xref>D).</p>
<table-wrap id="acn3622-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Subjects with causal variants in <italic>DDX3X</italic>
</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Subject</th>
<th align="left" colspan="1" rowspan="1" valign="top">Genotype<xref ref-type="fn" rid="acn3622-note-0008">a</xref>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Inheritance</th>
<th align="left" colspan="1" rowspan="1" valign="top">Nucleotide change</th>
<th align="left" colspan="1" rowspan="1" valign="top">Amino acid change</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutant/total reads by WES</th>
<th align="left" colspan="1" rowspan="1" valign="top">WES type</th>
<th align="left" colspan="1" rowspan="1" valign="top">Variant interpretation</th>
<th align="left" colspan="1" rowspan="1" valign="top">SIFT</th>
<th align="left" colspan="1" rowspan="1" valign="top">Polyphen2</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation taster</th>
<th align="left" colspan="1" rowspan="1" valign="top">Scaled CADD score</th>
<th align="left" colspan="1" rowspan="1" valign="top">Ref</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Female 1</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.14_17delCAGT</td>
<td align="left" colspan="1" rowspan="1">p.A5 fs</td>
<td align="left" colspan="1" rowspan="1">93/203</td>
<td align="left" colspan="1" rowspan="1">Trio</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 2</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.949T&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.C317R</td>
<td align="left" colspan="1" rowspan="1">130/265</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">27.9</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 3</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.126_129delTTTA</td>
<td align="left" colspan="1" rowspan="1">p.H42 fs</td>
<td align="left" colspan="1" rowspan="1">38/88</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PM2, PM6</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">33</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 4</td>
<td align="left" colspan="1" rowspan="1">Mosaic 21%</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.573_575del</td>
<td align="left" colspan="1" rowspan="1">p.I191del</td>
<td align="left" colspan="1" rowspan="1">69/327</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">22.3</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 5</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1244T&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.I415N</td>
<td align="left" colspan="1" rowspan="1">205/435</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS6, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">31</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 6</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.971C&gt;G</td>
<td align="left" colspan="1" rowspan="1">p.P324R</td>
<td align="left" colspan="1" rowspan="1">146/292</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">28.3</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 7</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1703C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.P568L</td>
<td align="left" colspan="1" rowspan="1">239/448</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PS2, PS4, PM1, PM2, PP3, PP5</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="acn3622-bib-0013">13</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 8</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
<xref ref-type="fn" rid="acn3622-note-0009">b</xref>
</td>
<td align="left" colspan="1" rowspan="1">c.336dupC</td>
<td align="left" colspan="1" rowspan="1">p.R113 fs</td>
<td align="left" colspan="1" rowspan="1">107/233</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">33</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 9</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.873_874insTATA</td>
<td align="left" colspan="1" rowspan="1">p.R292 fs</td>
<td align="left" colspan="1" rowspan="1">97/257</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">35</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 10</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.874C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R292*</td>
<td align="left" colspan="1" rowspan="1">119/229</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">39</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 11</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.887G&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.R296P</td>
<td align="left" colspan="1" rowspan="1">183/407</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 12</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1180_1185dupCGTGAT</td>
<td align="left" colspan="1" rowspan="1">p.R394_D395dup</td>
<td align="left" colspan="1" rowspan="1">70/182</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">19.5</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 13</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1600C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R534C</td>
<td align="left" colspan="1" rowspan="1">30/88</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PS2, PS4, PM1, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">31</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 14</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1600C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R534C</td>
<td align="left" colspan="1" rowspan="1">50/114</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PS2, PS4, PM1, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">31</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 15</td>
<td align="left" colspan="1" rowspan="1">Mosaic 14%</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1805G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.R602Q</td>
<td align="left" colspan="1" rowspan="1">19/137</td>
<td align="left" colspan="1" rowspan="1">Trio</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">27.9</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 16</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1804C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R602*</td>
<td align="left" colspan="1" rowspan="1">67/141</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">51</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 17</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.453_454del</td>
<td align="left" colspan="1" rowspan="1">p.S152 fs</td>
<td align="left" colspan="1" rowspan="1">173/372</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 18</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.173C&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.S58*</td>
<td align="left" colspan="1" rowspan="1">53/100</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PM2, PM6</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">36</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 19</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.192dupA</td>
<td align="left" colspan="1" rowspan="1">p.D65 fs</td>
<td align="left" colspan="1" rowspan="1">98/210</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="acn3622-bib-0013">13</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 20</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1595C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.T532M</td>
<td align="left" colspan="1" rowspan="1">79/171</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS6, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">33</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 21</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1033G&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.V345L</td>
<td align="left" colspan="1" rowspan="1">79/155</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">possibly damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">26.6</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 22</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">No parental samples</td>
<td align="left" colspan="1" rowspan="1">c.1386C&gt;G</td>
<td align="left" colspan="1" rowspan="1">p.Y462*</td>
<td align="left" colspan="1" rowspan="1">159/342</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PVS1, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">37</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 23</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.284+1G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.?</td>
<td align="left" colspan="1" rowspan="1">95/191</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">26.9</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 24</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.865‐1G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.?</td>
<td align="left" colspan="1" rowspan="1">58/163</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Pathogenic, PVS1, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">24.6</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 25</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1021T&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.C341R</td>
<td align="left" colspan="1" rowspan="1">65/126</td>
<td align="left" colspan="1" rowspan="1">Trio</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">26.4</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 26</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1244T&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.I415N</td>
<td align="left" colspan="1" rowspan="1">46/87</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS6, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">31</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 27</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1206_1208delCTT</td>
<td align="left" colspan="1" rowspan="1">p.F402del</td>
<td align="left" colspan="1" rowspan="1">108/235</td>
<td align="left" colspan="1" rowspan="1">Trio</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">NA (Provean: deleterious)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">18.88</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female 28</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1438A&gt;G</td>
<td align="left" colspan="1" rowspan="1">p.R480G</td>
<td align="left" colspan="1" rowspan="1">1821/3806</td>
<td align="left" colspan="1" rowspan="1">Trio</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2, PP3</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">disease causing</td>
<td align="left" colspan="1" rowspan="1">25.6</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Male 1</td>
<td align="left" colspan="1" rowspan="1">Hemi</td>
<td align="left" colspan="1" rowspan="1">From asymptomatic mother</td>
<td align="left" colspan="1" rowspan="1">c.1052G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.R351Q</td>
<td align="left" colspan="1" rowspan="1">50/50</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS6, PM2, PP5</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">benign</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">25.1</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="acn3622-bib-0011">11</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Male 2</td>
<td align="left" colspan="1" rowspan="1">Hemi</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.443+3A&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.?</td>
<td align="left" colspan="1" rowspan="1">87/88</td>
<td align="left" colspan="1" rowspan="1">Proband</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic, PS2, PM2</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">13.91</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fetus 1</td>
<td align="left" colspan="1" rowspan="1">Het</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">c.1304T&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.L435P</td>
<td align="left" colspan="1" rowspan="1">260/513</td>
<td align="left" colspan="1" rowspan="1">Trio</td>
<td align="left" colspan="1" rowspan="1">Variant of unknown significance, PS2, PM2, phenotypic match uncertain</td>
<td align="left" colspan="1" rowspan="1">deleterious</td>
<td align="left" colspan="1" rowspan="1">probably damaging</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">28.4</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="acn3622-note-0004">
<p>Variant interpretation column contains the clinical significance of the variant and the type of evidences supporting the interpretation based on the ACMG guidelines<xref ref-type="ref" rid="acn3622-bib-0015">15</xref> and the internal guidelines developed at Baylor Genetics (<ext-link ext-link-type="uri" xlink:href="https://www.baylorgenetics.com/variant-classification/">https://www.baylorgenetics.com/variant-classification/</ext-link>).</p>
</fn>
<fn id="acn3622-note-0005">
<p>NA: not applicable.</p>
</fn>
<fn id="acn3622-note-0006">
<p>WES type: Trio: trio WES; Proband: proband only WES.</p>
</fn>
<fn id="acn3622-note-0007">
<p>None of the variants above has been seen in ExAC (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>) or gnomAD.<xref ref-type="ref" rid="acn3622-bib-0022">22</xref>
</p>
</fn>
<fn id="acn3622-note-0008">
<label>a</label>
<p>Het: heterozygous. Hemi: hemizygous.</p>
</fn>
<fn id="acn3622-note-0009">
<label>b</label>
<p>Heterozygous in the similarly affected monozygotic twin sibling, negative in two other siblings.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<fig fig-type="Figure" id="acn3622-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Location of <italic><styled-content style="fixed-case">DDX</styled-content>3X</italic> variants identified in this study, Female individuals (25, 26, 27) ascertained through the <styled-content style="fixed-case">BHCMG</styled-content>, and muscle biopsy results in Female 17 showing abnormal mitochondrial morphology. (A) Schematic view of the <italic><styled-content style="fixed-case">DDX</styled-content>3X</italic> exon–intron structure based on <styled-content style="fixed-case">NM</styled-content>_001193416. Blue boxes represent exons and yellow fields represent introns. Exon number is listed below each exon. <styled-content style="fixed-case">cDNA</styled-content> change is listed for each variant. (B) Schematic view of the <styled-content style="fixed-case">DDX</styled-content>3X protein structure based on Snijders Blok et al.<xref ref-type="ref" rid="acn3622-bib-0011">11</xref> Amino acid change is listed for each variant. (C) Pedigree and Sanger tracings demonstrate de <italic>novo</italic> inheritance in three unrelated female probands. (D) Female 25 demonstrated synophrys, a broad nasal root with upturned nostrils, a long philtrum, and thin upper lip. Female 27 demonstrated cupped ears, a long philtrum, and a thin upper lip. (E–G) Muscle biopsy results in Female 17 (E) Skeletal muscle cross‐section showing mild variation in fiber size (H&amp;E; magnification ×400). (F) Skeletal muscle cross‐section showing few fibers with mild subsarcolemmal increase in oxidative activity [cytochrome oxidase (long arrow) and NADH tetrazolium reductase (inset – arrow heads; magnifications ×400)]. (G) Electron microscopic images showing mild subsarcolemmal mitochondrial proliferation (long arrow) with inset in the upper corner showing pleomorphic abnormally elongated and irregularly shaped mitochondria (arrow heads). Variant color in (A) and (B): black, first reported in this study; purple, previously reported. The c.1304T&gt;C (p.L435P) variant from Fetus 1 was not listed in (A) and (B).</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="ACN3-5-1277-g001"></graphic>
</fig>
<table-wrap id="acn3622-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Comparison of clinical presentations in this study and in the published cohort</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Clinical features</th>
<th align="left" colspan="1" rowspan="1" valign="top">Number of subjects in this study</th>
<th align="left" colspan="1" rowspan="1" valign="top">Percentage in this study</th>
<th align="left" colspan="1" rowspan="1" valign="top">Percentage in the published cohort</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">DD and/or ID</td>
<td align="left" colspan="1" rowspan="1">28/28</td>
<td align="left" colspan="1" rowspan="1">100%</td>
<td align="left" colspan="1" rowspan="1">100%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hypotonia</td>
<td align="left" colspan="1" rowspan="1">19/28</td>
<td align="left" colspan="1" rowspan="1">68%</td>
<td align="left" colspan="1" rowspan="1">76%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dysmorphic features</td>
<td align="left" colspan="1" rowspan="1">19/28</td>
<td align="left" colspan="1" rowspan="1">68%</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Structural brain abnormalities</td>
<td align="left" colspan="1" rowspan="1">18/20</td>
<td align="left" colspan="1" rowspan="1">90%</td>
<td align="left" colspan="1" rowspan="1">81%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Movement disorders</td>
<td align="left" colspan="1" rowspan="1">17/28</td>
<td align="left" colspan="1" rowspan="1">61%</td>
<td align="left" colspan="1" rowspan="1">45%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Visual impairments</td>
<td align="left" colspan="1" rowspan="1">9/28</td>
<td align="left" colspan="1" rowspan="1">32%</td>
<td align="left" colspan="1" rowspan="1">34%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Microcephaly</td>
<td align="left" colspan="1" rowspan="1">7/28</td>
<td align="left" colspan="1" rowspan="1">25%</td>
<td align="left" colspan="1" rowspan="1">32%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Autism spectrum disorders and other behavior problems<xref ref-type="fn" rid="acn3622-note-0011">a</xref>
</td>
<td align="left" colspan="1" rowspan="1">6/28</td>
<td align="left" colspan="1" rowspan="1">21%</td>
<td align="left" colspan="1" rowspan="1">53%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Respiratory problems</td>
<td align="left" colspan="1" rowspan="1">5/28</td>
<td align="left" colspan="1" rowspan="1">18%</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital heart disease</td>
<td align="left" colspan="1" rowspan="1">5/7</td>
<td align="left" colspan="1" rowspan="1">71%</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Skin abnormalities<xref ref-type="fn" rid="acn3622-note-0011">a</xref>
</td>
<td align="left" colspan="1" rowspan="1">5/28</td>
<td align="left" colspan="1" rowspan="1">18%</td>
<td align="left" colspan="1" rowspan="1">37%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="acn3622-note-0010">
<p>NA, not specified or reported in the published study.<xref ref-type="ref" rid="acn3622-bib-0010">10</xref>
</p>
</fn>
<fn id="acn3622-note-0011">
<label>a</label>
<p>In comparison to published data, autism spectrum disorder and other behavior problems and skin abnormalities are underrepresented in our cohort: 6<italic>/</italic>28 versus 20/38 (<italic>P </italic>=<italic> </italic>5.2 × 10<sup>−3</sup>) and 5/28 versus 14/38 (<italic>P </italic>=<italic> </italic>4.6 × 10<sup>−2</sup>), respectively. One‐tailed <italic>Z</italic> score test for two population proportions is used.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In two subjects undergoing muscle biopsy, skeletal muscle mitochondrial DNA content was reduced. The first subject (Female 17) is a 6‐year‐old nondysmorphic girl with a history of neonatal hypotonia, esophageal reflux, and global developmental delay. A quadriceps muscle biopsy demonstrated mild fiber type variation and abnormal pleomorphic mitochondria on electron microscopy (Fig. <xref ref-type="fig" rid="acn3622-fig-0001">1</xref>E–G). After correction for the reduced citrate synthase activity, respiratory chain enzyme activity analysis demonstrated reductions of multiple complexes, with relative sparing of complex II activity. Sequencing of mitochondrial DNA from the muscle sample did not detect any known or likely pathogenic variants. Mitochondrial DNA content in muscle was 39% of age‐matched control muscle. Clinical WES demonstrated a <italic>de novo</italic> heterozygous c.453_454del (p.S152 fs) pathogenic variant in <italic>DDX3X</italic>, with no other variants in known disease‐associated genes that explain the patient's clinical presentations. The second subject is a 47‐year‐old woman (Female 13) with history of global developmental delay, intellectual disability, short stature, dysmorphic features, microcephaly, and unilateral renal agenesis. She learned to sit at two years of age and walk at eight, and she only learned to say simple words. In her early 40 sec, she regressed, becoming nonverbal and unable to ambulate or to use her arms. She was found to carry a <italic>de novo</italic> heterozygous c.1600C&gt;T (p.R534C) pathogenic variant in <italic>DDX3X</italic> (Table <xref ref-type="table" rid="acn3622-tbl-0001">1</xref>). The same variant was also observed in Female 14 in our cohort, and a variant involving the same codon (p.R534H) has been reported in a patient with ID.<xref ref-type="ref" rid="acn3622-bib-0011">11</xref> A quadriceps muscle biopsy demonstrated severe mitochondrial and lipid depletion, and reduction in mitochondrial size similar to Female 17. Mitochondrial DNA content in muscle was 26% of the mean value for age‐ and tissue‐matched controls. A reduction in all mitochondrial respiratory chain complex activities was observed. However, the reduction do not meet diagnostic criteria after correction for the low citrate synthase activity.</p>
</sec>
<sec id="acn3622-sec-0004">
<title>Discussion</title>
<p>Normal RNA metabolism requires the function of RNA helicases (RH), and yet, the exact function of most human RH remains unknown. There are six superfamilies of RH known with more than 50 human members in superfamily two that are characterized by a DExH and DExD signature in their Walker B motifs, thus termed DHX and DDX proteins. Genetic studies have begun to address the role of altered RH function in human disease (e.g., <italic>DHX37</italic> and <italic>DHX30</italic>).<xref ref-type="ref" rid="acn3622-bib-0016">16</xref>, <xref ref-type="ref" rid="acn3622-bib-0017">17</xref>
<italic>DDX3X</italic> encodes a DEAD‐box RNA helicase important in transcription, splicing, RNA transport, and translation.<xref ref-type="ref" rid="acn3622-bib-0018">18</xref>, <xref ref-type="ref" rid="acn3622-bib-0019">19</xref> In a diagnostic laboratory referral cohort of 4839 subjects with DD and/or ID, we have identified 26 postnatal individuals (24 females, 2 males) with syndromic ID or DD carrying pathogenic or likely pathogenic variants in <italic>DDX3X</italic>, and one fetus with abnormal ultrasound findings carrying a <italic>de novo</italic> variant of unknown significance in <italic>DDX3X</italic>; an additional four females were identified through research WES at BHCMG. The overall frequency of pathogenic or likely pathogenic <italic>DDX3X</italic> variations in our diagnostic laboratory referral cohort is 0.54% of the total (26/4839) and 1.12% of females (24/2152), similar to a previous report (0.6% and 1.5% respectively),<xref ref-type="ref" rid="acn3622-bib-0010">10</xref> confirming mutations in <italic>DDX3X</italic> are one of the most common genetic causes of unexplained ID in females. In our diagnostic laboratory, <italic>DDX3X</italic> ranks third among approximately 450 genes for the occurrence of <italic>de novo</italic> variants, with <italic>ARID1B</italic> first (43 individuals) and <italic>ANKRD11</italic> sec (29 individuals).</p>
<p>In addition to confirming and extending published mutational data, our phenotypic analyses expand the phenotypic spectrum associated with <italic>DDX3X</italic> variants in females. For instance, we found respiratory problems and congenital heart disease in 5/28 and 5/7 of our subjects, phenotypes not previously described in the original description of <italic>DDX3X</italic> related disorders,<xref ref-type="ref" rid="acn3622-bib-0011">11</xref> although observed in a subsequent report of two females.<xref ref-type="ref" rid="acn3622-bib-0012">12</xref> We found no evidence for genotype–phenotype correlations between the mutations we identified and age at onset or phenotypic severity. Previously reported individuals ranged in ages from 1 to 33 years. We report the phenotype of a 47‐year‐old woman (Female 13) who had manifestations consistent with <italic>DDX3X</italic> disorder and a clinical picture of previously unreported late‐onset neurologic decline. The decline is unrelated to intercurrent illness, and her motor function is at least in part responsive to physical therapy. Of note, other X‐linked DD/ID loci, exemplified by female <italic>FMR1</italic> premutation [MIM: 300623] and <italic>MECP2</italic> duplication carriers,<xref ref-type="ref" rid="acn3622-bib-0020">20</xref> are notable for late adult onset neurological or neurocognitive phenotypes.</p>
<p>Two variants reported in this study, c.1600C&gt;T (p.R534C) and c.1703C&gt;T (p.P568L), and three previously reported, c.641T&gt;C (p.I214T), c.931C&gt;T (p.R311*), and c.1084C&gt;T (p.R362C),<xref ref-type="ref" rid="acn3622-bib-0011">11</xref> have also been observed to occur somatically in association with medulloblastoma, malignant melanoma, and esophageal squamous cell carcinoma (<ext-link ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cosmic">http://cancer.sanger.ac.uk/cosmic</ext-link>). Malignancy has not been reported in the 31 patients included in this study. However, pathway analysis for the highest 5% and lowest 5% genes expressed in RNAseq data from dermal fibroblasts obtained in one subject (Female 13) showed enrichment in cell cycle control of chromosomal replication and double‐strand break repair pathways (Table <xref ref-type="supplementary-material" rid="acn3622-sup-0003">S2</xref>). Future studies will elucidate whether individuals carrying <italic>DDX3X</italic> variants are at risk for the development of malignancies.<xref ref-type="ref" rid="acn3622-bib-0021">21</xref> In summary, we identified 31 unrelated patients with causal variants in <italic>DDX3X</italic> and expanded the genotypic and phenotypic spectrum of <italic>DDX3X</italic>‐related disorders. The collective data suggest that <italic>DDX3X</italic> defects are a frequent cause of syndromic ID in females, and the causal variants are likely to be loss‐of‐function (ExAC database showed pLI = 1.00 for <italic>DDX3X</italic>).<xref ref-type="ref" rid="acn3622-bib-0022">22</xref>
</p>
</sec>
<sec id="acn3622-sec-0006">
<title>Author Contributions</title>
<p>Conception and design of the study: X. W., B. L., J. R. L., B. H. G., P. M. Acquisition and analysis of data: X. W., J. E. P., J. A. R., B. L., J. R. L., B. H. G., P. M. C. A. B., F. S., L. I., J. M. H., S. E. H., T. M. M., A. S., J. Z., J. B., M. S. L., W. H., F. V., M. A. W., W. B., R. X., P. F. L., Y. S., A. G., E. Y. G., Y. J., S. A. D., A. W. H., M. M. K., D. P., J. P., D. M. M., N. H., J. W. B., L. V. M., R. A. G., M. K. E., Z. C. A., T. H., A. M. A., S. C., C. M. E., F. X., Y. Y. Drafting a significant portion of the manuscript or figures: X. W., J. E. P., J. A. R., J. R. L., B. H. G., P. M.</p>
</sec>
<sec id="acn3622-sec-0007">
<title>Conflicts of Interest</title>
<p>The Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing done at Baylor Genetics. J. R. L. has stock ownership in 23 and Me, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc and is a co‐inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="acn3622-sup-0001">
<caption>
<p>
<bold>Figure S1.</bold> Brain MRI images of subjects with <italic>DDX3X</italic> variants.</p>
</caption>
<media xlink:href="ACN3-5-1277-s001.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="acn3622-sup-0002">
<caption>
<p>
<bold>Table S1.</bold> Clinical features and <italic>DDX3X</italic> variants in subjects enrolled in this study. Detailed clinical features are only reported for the subjects in whom we were able to obtain additional informed consent.</p>
</caption>
<media xlink:href="ACN3-5-1277-s002.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="acn3622-sup-0003">
<caption>
<p>
<bold>Table S2.</bold> RNAseq pathway analysis for Female 13.</p>
</caption>
<media xlink:href="ACN3-5-1277-s003.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="acn3622-sup-0004">
<caption>
<p>
<bold>Table S3.</bold> Members of the Undiagnosed Diseases Network.</p>
</caption>
<media xlink:href="ACN3-5-1277-s004.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="acn3622-sec-0005">
<title>Acknowledgments</title>
<p>We are deeply grateful to the patients and clinicians whose participation made this study possible. Research reported in this manuscript was supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under Award Number U01HG007709, and the National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) UM1 HG006542 to the Baylor Hopkins Center for Mendelian Genomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J. E. P. was supported by K08 HG008986 through the National Human Genome Research Institute.</p>
</ack>
<ref-list content-type="cited-references" id="acn3622-bibl-0001">
<title>References</title>
<ref id="acn3622-bib-0001">
<label>1</label>
<mixed-citation id="acn3622-cit-0001" publication-type="journal">
<string-name>
<surname>Maulik</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Mascarenhas</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Mathers</surname>
<given-names>CD</given-names>
</string-name>, et al. <article-title>Prevalence of intellectual disability: a meta‐analysis of population‐based studies</article-title>. <source xml:lang="en"/>Res Dev Disabil
<year>2011</year>;<volume>32</volume>:<fpage>419</fpage>–<lpage>436</lpage>.<pub-id pub-id-type="pmid">21236634</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0002">
<label>2</label>
<mixed-citation id="acn3622-cit-0002" publication-type="journal">
<string-name>
<surname>Lubs</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Stevenson</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
<given-names>CE</given-names>
</string-name>. <article-title>Fragile X and X‐linked intellectual disability: four decades of discovery</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2012</year>;<volume>90</volume>:<fpage>579</fpage>–<lpage>590</lpage>.<pub-id pub-id-type="pmid">22482801</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0003">
<label>3</label>
<mixed-citation id="acn3622-cit-0003" publication-type="journal">
<string-name>
<surname>Bassani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zapata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gerosa</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>The neurobiology of X‐linked intellectual disability</article-title>. <source xml:lang="en"/>Neuroscientist
<year>2013</year>;<volume>19</volume>:<fpage>541</fpage>–<lpage>552</lpage>.<pub-id pub-id-type="pmid">23820068</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0004">
<label>4</label>
<mixed-citation id="acn3622-cit-0004" publication-type="journal">
<string-name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Filauro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tomson</surname>
<given-names>BN</given-names>
</string-name>, et al. <article-title>Inheritance of most X‐linked traits is not dominant or recessive, just X‐linked</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2004</year>;<volume>129A</volume>:<fpage>136</fpage>–<lpage>143</lpage>.<pub-id pub-id-type="pmid">15316978</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0005">
<label>5</label>
<mixed-citation id="acn3622-cit-0005" publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Muzny</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Reid</surname>
<given-names>JG</given-names>
</string-name>, et al. <article-title>Clinical whole‐exome sequencing for the diagnosis of mendelian disorders</article-title>. <source xml:lang="en"/>N Engl J Med
<year>2013</year>;<volume>369</volume>:<fpage>1502</fpage>–<lpage>1511</lpage>.<pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0006">
<label>6</label>
<mixed-citation id="acn3622-cit-0006" publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Muzny</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Molecular findings among patients referred for clinical whole‐exome sequencing</article-title>. <source xml:lang="en"/>JAMA
<year>2014</year>;<volume>312</volume>:<fpage>1870</fpage>–<lpage>1879</lpage>.<pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0007">
<label>7</label>
<mixed-citation id="acn3622-cit-0007" publication-type="journal">
<string-name>
<surname>Posey</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>RA</given-names>
</string-name>, et al. <article-title>Molecular diagnostic experience of whole‐exome sequencing in adult patients</article-title>. <source xml:lang="en"/>Genet Med
<year>2016</year>;<volume>18</volume>:<fpage>678</fpage>–<lpage>685</lpage>.<pub-id pub-id-type="pmid">26633545</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0008">
<label>8</label>
<mixed-citation id="acn3622-cit-0008" publication-type="journal">
<string-name>
<surname>de Lange</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Helbig</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Weckhuysen</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>De novo mutations of <italic>KIAA2022</italic> in females cause intellectual disability and intractable epilepsy</article-title>. <source xml:lang="en"/>J Med Genet
<year>2016</year>;<volume>53</volume>:<fpage>850</fpage>–<lpage>858</lpage>.<pub-id pub-id-type="pmid">27358180</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0009">
<label>9</label>
<mixed-citation id="acn3622-cit-0009" publication-type="journal">
<string-name>
<surname>Zweier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kraus</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brueton</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>A new face of Borjeson‐Forssman‐Lehmann syndrome? De novo mutations in <italic>PHF6</italic> in seven females with a distinct phenotype</article-title>. <source xml:lang="en"/>J Med Genet
<year>2013</year>;<volume>50</volume>:<fpage>838</fpage>–<lpage>847</lpage>.<pub-id pub-id-type="pmid">24092917</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0010">
<label>10</label>
<mixed-citation id="acn3622-cit-0010" publication-type="journal">
<string-name>
<surname>Reijnders</surname>
<given-names>MRF</given-names>
</string-name>, <string-name>
<surname>Zachariadis</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Latour</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>De novo loss‐of‐function mutations in USP9X cause a female‐specific recognizable syndrome with developmental delay and congenital malformations</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2016</year>;<volume>98</volume>:<fpage>373</fpage>–<lpage>381</lpage>.<pub-id pub-id-type="pmid">26833328</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0011">
<label>11</label>
<mixed-citation id="acn3622-cit-0011" publication-type="journal">
<string-name>
<surname>Snijders Blok</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Madsen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Juusola</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Mutations in <italic>DDX3X</italic> are a common cause of unexplained intellectual disability with gender‐specific effects on Wnt signaling</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2015</year>;<volume>97</volume>:<fpage>343</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">26235985</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0012">
<label>12</label>
<mixed-citation id="acn3622-cit-0012" publication-type="journal">
<string-name>
<surname>Dikow</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Granzow</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Graul‐Neumann</surname>
<given-names>LM</given-names>
</string-name>, et al. <article-title>
<italic>DDX3X</italic> mutations in two girls with a phenotype overlapping Toriello‐Carey syndrome</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2017</year>;<volume>173</volume>:<fpage>1369</fpage>–<lpage>1373</lpage>.<pub-id pub-id-type="pmid">28371085</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0013">
<label>13</label>
<mixed-citation id="acn3622-cit-0013" publication-type="journal">
<string-name>
<surname>Eldomery</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Coban‐Akdemir</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Harel</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Lessons learned from additional research analyses of unsolved clinical exome cases</article-title>. <source xml:lang="en"/>Genome Med
<year>2017</year>;<volume>9</volume>:<fpage>26</fpage>.<pub-id pub-id-type="pmid">28327206</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0014">
<label>14</label>
<mixed-citation id="acn3622-cit-0014" publication-type="journal">
<string-name>
<surname>Posey</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Harel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Resolution of disease phenotypes resulting from multilocus genomic variation</article-title>. <source xml:lang="en"/>N Engl J Med
<year>2017</year>;<volume>376</volume>:<fpage>21</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">27959697</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0015">
<label>15</label>
<mixed-citation id="acn3622-cit-0015" publication-type="journal">
<string-name>
<surname>Richards</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bale</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source xml:lang="en"/>Genet Med
<year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0016">
<label>16</label>
<mixed-citation id="acn3622-cit-0016" publication-type="journal">
<string-name>
<surname>Lessel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schob</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Küry</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>De novo missense mutations in <italic>DHX30</italic> impair global translation and cause a neurodevelopmental disorder</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2017</year>;<volume>101</volume>:<fpage>716</fpage>–<lpage>724</lpage>.<pub-id pub-id-type="pmid">29100085</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0017">
<label>17</label>
<mixed-citation id="acn3622-cit-0017" publication-type="journal">
<string-name>
<surname>Karaca</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Harel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease</article-title>. <source xml:lang="en"/>Neuron
<year>2015</year>;<volume>88</volume>:<fpage>499</fpage>–<lpage>513</lpage>.<pub-id pub-id-type="pmid">26539891</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0018">
<label>18</label>
<mixed-citation id="acn3622-cit-0018" publication-type="journal">
<string-name>
<surname>Abdelhaleem</surname>
<given-names>M</given-names>
</string-name>. <article-title>RNA helicases: regulators of differentiation</article-title>. <source xml:lang="en"/>Clin Biochem
<year>2005</year>;<volume>38</volume>:<fpage>499</fpage>–<lpage>503</lpage>.<pub-id pub-id-type="pmid">15885226</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0019">
<label>19</label>
<mixed-citation id="acn3622-cit-0019" publication-type="journal">
<string-name>
<surname>Garbelli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Beermann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Di Cicco</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>A motif unique to the human DEAD‐box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV‐1 replication</article-title>. <source xml:lang="en"/>PLoS ONE
<year>2011</year>;<volume>6</volume>:<fpage>e19810</fpage>.<pub-id pub-id-type="pmid">21589879</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0020">
<label>20</label>
<mixed-citation id="acn3622-cit-0020" publication-type="journal">
<string-name>
<surname>Ramocki</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>SU</given-names>
</string-name>, <string-name>
<surname>Tavyev</surname>
<given-names>YJ</given-names>
</string-name>, et al. <article-title>Autism and other neuropsychiatric symptoms are prevalent in individuals with <italic>MeCP2</italic> duplication syndrome</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2009</year>;<volume>66</volume>:<fpage>771</fpage>–<lpage>782</lpage>.<pub-id pub-id-type="pmid">20035514</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0021">
<label>21</label>
<mixed-citation id="acn3622-cit-0021" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Charng</surname>
<given-names>W‐L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C‐A</given-names>
</string-name>, et al. <article-title>Germline mutations in <italic>ABL1</italic> cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations</article-title>. <source xml:lang="en"/>Nat Genet
<year>2017</year>;<volume>49</volume>:<fpage>613</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">28288113</pub-id></mixed-citation>
</ref>
<ref id="acn3622-bib-0022">
<label>22</label>
<mixed-citation id="acn3622-cit-0022" publication-type="journal">
<string-name>
<surname>Lek</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</string-name>, et al. <article-title>Analysis of protein‐coding genetic variation in 60,706 humans</article-title>. <source xml:lang="en"/>Nature
<year>2016</year>;<volume>536</volume>:<fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>